1-4 of 4
Gema Moreno-Bueno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

Free
Ángela Molina-Crespo, Ana Cadete, David Sarrio, Manuel Gámez-Chiachio, Lidia Martinez, Kinlin Chao, Ana Olivera, Andrea Gonella, Eva Díaz, José Palacios, Pradeep K. Dhal, Magnus Besev, Macarena Rodríguez-Serrano, María Laura García Bermejo, Juan Carlos Triviño, Amparo Cano, Marcos García-Fuentes, Osnat Herzberg, Dolores Torres, Maria José Alonso, Gema Moreno-Bueno
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (15): 4846–4858.
https://doi.org/10.1158/1078-0432.CCR-18-2381
Published: 01 August 2019
View articletitled, Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness
Open the PDF for Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness in another window
Includes: Supplementary data
Journal Articles

Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

Free
Rachael Natrajan, Maryou B. Lambros, Socorro María Rodríguez-Pinilla, Gema Moreno-Bueno, David S.P. Tan, Caterina Marchió, Radost Vatcheva, Sydonia Rayter, Betania Mahler-Araujo, Laura G. Fulford, Daniela Hungermann, Alan Mackay, Anita Grigoriadis, Kerry Fenwick, Narinder Tamber, David Hardisson, Andrew Tutt, Jose Palacios, Christopher J. Lord, Horst Buerger, Alan Ashworth, Jorge S. Reis-Filho
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (8): 2711–2722.
https://doi.org/10.1158/1078-0432.CCR-08-1878
Published: 15 April 2009
View articletitled, Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Open the PDF for Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas

Free
Gema Moreno-Bueno, Carolina Sanchez-Estevez, José Palacios, David Hardisson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (12): 3865–3866.
https://doi.org/10.1158/1078-0432.CCR-06-0284
Published: 15 June 2006
View articletitled, Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas
Open the PDF for Low Frequency of BRAF Mutations in Endometrial and in Cervical Carcinomas in another window
Journal Articles

Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225): Superiority Over Single-Agent Receptor Targeting

Free
Pablo Matar, Federico Rojo, Raúl Cassia, Gema Moreno-Bueno, Serena Di Cosimo, José Tabernero, Marta Guzmán, Sonia Rodriguez, Joaquín Arribas, José Palacios, José Baselga
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6487–6501.
https://doi.org/10.1158/1078-0432.CCR-04-0870
Published: 08 October 2004
View articletitled, Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225): Superiority Over Single-Agent Receptor Targeting
Open the PDF for Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225): Superiority Over Single-Agent Receptor Targeting in another window